Latest News

Through this acquisition, the company strengthens its ability to support cell therapy developers with integrated manufacturing, processing, and cryopreservation services under a unified platform.

The newly established caucus aims to strengthen political leadership, policy development, financing, and accountability in the national fight against TB.

Isomorphic Labs plans to use the new capital to further develop and deploy its proprietary AI drug design engine, known as IsoDDE.

Four deaths have already been confirmed through laboratory testing, while additional suspected cases remain under investigation in Bunia, a densely populated urban centre in Ituri province.

The acquisition will give Zydus access to Assertio’s commercial infrastructure in the US specialty pharmaceutical market, particularly in oncology supportive care and pain management therapies.

Regulators approved the drug as an additional therapy for patients whose blood pressure remains uncontrolled despite using standard antihypertensive medicines.

The approval applies to adolescents and adults weighing at least 35 kilograms who have haemophilia A with factor VIII inhibitors or haemophilia B with factor IX inhibitors.

NICE recommended Imfinzi for adults whose stomach cancer has not spread extensively and can be removed through surgery, including gastric and gastro-oesophageal junction cancers that physicians frequently diagnose at advanced stages.

The acquisition includes MacroGenics’ biologics drug substance manufacturing facility in Rockville, Maryland, as well as a warehousing center in Frederick, Maryland, located about 30 miles away.

In addition, the investment will strengthen research into emerging treatment areas such as heart failure and renal denervation, a minimally invasive therapy for uncontrolled hypertension.